Devlin, James J.

Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials

Mega, J. L., Stitziel, N. O., Smith, J. G., Chasman, D. I., Caulfield, M. J., Devlin, J. J., Nordio, F., Hyde, C. L., Cannon, C. P., Sacks, F. M., et al. (2015) · The Lancet

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 704

Organization and evolution of the class I gene family in the major histocompatibility complex of the C57BL/10 mouse

Weiss, E. H., Golden, L., Fahrner, K., Mellor, A. L., Devlin, J. J., Bullman, H., Tiddens, H., Bud, H., & Flavell, R. A. (1984) · Nature

vaccines and immunoinformatics approachesGenetic Associations and Epidemiology

Cited by 316

Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history

Tada, H., Melander, O., Louie, J. Z., Catanese, J. J., Rowland, C. M., Devlin, J. J., Kathiresan, S., & Shiffman, D. (2016) · European Heart Journal

Genetic Associations and EpidemiologyNutrition, Genetics, and Disease

Cited by 285

Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke

Tada, H., Shiffman, D., Smith, J. G., Sjögren, M., Lubitz, S. A., Ellinor, P. T., Louie, J. Z., Catanese, J. J., Engström, G., Devlin, J. J., et al. (2014) · Stroke

Atrial Fibrillation Management and OutcomesGenetic Associations and Epidemiology

Cited by 110